Clive Hyman, a 64-year-old finance executive, died following a minor fall despite feeling fine immediately afterward. He had an active lifestyle and was known for his achievements in the finance sector, having been the youngest partner at KPMG. Tragically, after inadequate assessment of his fall-related injuries, he suffered a brain haemorrhage caused by his blood thinner medication, apixaban, which he was prescribed due to heart issues.

The inquest revealed that nine days after the fall, Hyman was hospitalized and succumbed to his injuries, raising significant concerns regarding the use of blood thinners like apixaban, which are known to increase the risk of bleeding in certain situations. His wife has stated that he could have been saved if more careful monitoring and intervention had occurred following his fall. This incident has sparked discussions about patient safety and the protocols regarding the prescription of anticoagulants to ensure that patients are adequately informed about the associated risks.

The coroner's findings emphasize the critical need for healthcare professionals to assess patients more thoroughly when they are on blood thinners after any head trauma, no matter how minor it may seem. This case may lead to changes in how these medications are prescribed and monitored in the healthcare system, highlighting the potential dangers of apixaban and similar drugs when it comes to accidental injuries.